Ionis Reports Fourth Quarter and Full Year 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Ionis Pharmaceuticals (IONS) PT Raised to $57 at Stifel
February 28, 2018 6:39 AM ESTStifel raised its price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $57.00 (from $55.00) while maintaining a Hold rating.
Analyst Stephen Willey notes SPINRAZA royalties highlight increasing leverage, with IONIS-HTTRx data now on deck.
... More